2026 Drug Cost Guide: Keytruda, Wegovy, Mounjaro, Zepbound, Opdivo & Imfinzi Prices

Updated U.S. drug cost data (Keytruda, Wegovy, Mounjaro, Zepbound) — Insurance, savings & 2026 trends.

Showing 13 - 16 of 16 drug pricing articles
Keytruda Price Per Infusion in USA | Updated 2025 Guide - 2026 Drug Cost Analysis

Keytruda Price Per Infusion in USA | Updated 2025 Guide

328 views

If you or a loved one is considering immunotherapy, understanding the real cost of treatment is crucial. In 2025, the price of Keytruda (pembrolizumab) per infusion in the USA remains a major factor for patients, caregivers, and healthcare providers. On average, a single infusion can cost between $9,800 and $11,500, depending on insurance coverage, treatment duration, and hospital charges. This updated guide explores the latest Keytruda prices, available financial assistance programs, and key insurance considerations to help you plan more effectively. You’ll also find official resources, FAQs, and expert insights, making this one of the most comprehensive guides to Keytruda treatment costs in the USA today.

How Much Does Opdivo Cost in the USA? | Nivolumab Price 2025 - 2026 Drug Cost Analysis

How Much Does Opdivo Cost in the USA? | Nivolumab Price 2025

343 views

In 2025, the cost of Opdivo (nivolumab) in the United States remains a major concern for cancer patients and caregivers. With list prices starting at around $7,600 per infusion and reaching over $36,000 per vial, understanding insurance coverage, financial assistance programs, and the newly approved subcutaneous form (Opdivo Qvantig) is essential. This guide explains the latest prices, cost-saving options, and answers the most common questions about Opdivo treatment in the U.S.

Keytruda Cost in the USA: How Much Does Pembrolizumab Really Cost in 2025? - 2026 Drug Cost Analysis

Keytruda Cost in the USA: How Much Does Pembrolizumab Really Cost in 2025?

907 views

Keytruda (pembrolizumab) is one of the most widely used immunotherapy drugs for treating different types of cancer, including lung cancer, melanoma, and head and neck cancers. In the United States, the cost of Keytruda can be a major concern for patients and their families, as it is often priced at several thousand dollars per infusion. This article explores the average cost of Keytruda in the USA, insurance coverage options, financial assistance programs, and helpful resources for patients seeking more affordable access.

Keytruda for Lung Cancer: Cost, Treatment, Survival Rate, and Side Effects - 2026 Drug Cost Analysis

Keytruda for Lung Cancer: Cost, Treatment, Survival Rate, and Side Effects

230 views

Keytruda (pembrolizumab) is a breakthrough immunotherapy for lung cancer that helps the immune system recognize and attack cancer cells. Unlike chemotherapy, Keytruda targets the PD-1/PD-L1 pathway, improving survival rates in patients with non-small cell lung cancer (NSCLC) and certain cases of small cell lung cancer (SCLC). This guide explains how Keytruda works, its cost, side effects, FDA approval, alternatives, and what patients can expect from treatment.

Drug Price FAQs: Keytruda, Wegovy, Mounjaro & More

The average cost of Keytruda without insurance in 2026 is around $10,000 to $13,000 per dose. With insurance, out-of-pocket expenses can be as low as $100 depending on the coverage.

Experts expect Zepbound’s price to drop by 10–15% in 2026 as competition and insurance coverage expand. Savings cards and manufacturer programs are also expected to continue.

Wegovy costs between $25 and $150 per month with most insurance plans in the U.S. Without insurance, the price is around $1,350 monthly.

Top Drug Comparisons 2026: Keytruda, Mounjaro, Wegovy & Zepbound

Keytruda vs Opdivo

Compare the 2026 cost, effectiveness, and insurance coverage of both cancer treatments.

Compare Now

Wegovy vs Zepbound

Find out which weight-loss drug offers the best value and results in 2026.

Read Comparison

Mounjaro Savings 2026

Learn how to get the best savings and discounts for Mounjaro through insurance and cards.

See Savings